Five policy highlights of domestic pharmaceutical industry this year

The new medical reform was announced and implemented in 2009, and many policies will continue to ferment in the next few years In 2014, the five major policies of the pharmaceutical industry have the following points: 1 The revision of the drug administration law by the drug administration law is the mother law of drug supervision, and the new drug administration law is expected to speed up the development and marketing of generic drugs in China and improve the testing period of new drugs Pharmaceutical companies generally expect the new law to be able to revise the drug listing licensing system and drug approval mechanism The new "Drug Administration Law" will make the retail chain operation, third-party logistics, drug export, auxiliary material management, drug recall and other fields more law-abiding 2 On February 7 of this year, the State Council held a standing meeting to decide to merge the new rural social endowment insurance and the urban residents' social endowment insurance, and establish a unified national basic endowment insurance system for urban and rural residents The integration of the new rural cooperative medical system and the old-age insurance for urban residents means that the integration of the three insurances is not far away (Anhui Province has completed it ahead of schedule in March 2014) Once the three guarantees are integrated, the gap between the per capita financing level of NCMS and urban residents is likely to narrow, thus stimulating the demand for medicine, which will bring a great increase to the medicine market 3 The State Council medical reform office issued the notice on accelerating the work of serious illness insurance for urban and rural residents (Guo Yi Gai Ban Fa [2014] No 1) on February 8, which pointed out that provinces that have not yet carried out the pilot work of serious illness insurance for urban and rural residents should start the pilot work before the end of June 2014 The pilot project will establish and improve the coordination and promotion mechanism led by the medical reform office and participated by the development and Reform Commission, finance, social security, civil affairs, health and family planning, insurance supervision and other departments 4 The supply of medical services to encourage social hospitals is still tight Although the high load use of beds in hospitals above the second level is slightly relieved, it is still high The national policy encourages social capital to run hospitals When the private hospitals are further covered by medical insurance and the management of professional titles is implemented, the private hospitals will usher in a period of rapid development From 2008 to 2012, the number of private hospitals increased by 18% annually and the number of beds increased by 19% Considering the government's target of 20% of private hospitals' service volume in 2015, the annual growth rate of private hospitals' patient volume from now to 2015 will be as high as 30% 5 Price mechanism In the future, the formation mechanism of drug price will focus on several key points: the market decides the price, the government indirectly guides and pays the binding expenses; the core of the mechanism is to rebuild the competition mechanism of drug health; the key point is to mobilize the enthusiasm of the main unit of purchase and use; the three links of pricing, bidding and reimbursement are closely linked.